- alias::
  ICD-11_Code::
  tags:: disease
- ## Etiology
  background-color:: blue
	- ### Causative Agents
	- ### Risk Factors
- ## Epidemiology
  background-color:: blue
	- ### Incidence
	- ### Prevalence
		- ### Demographics
	- ### Geographic Distribution
- ## Pathophysiology
  background-color:: blue
	- ### Mechanism of Disease
	- ### Affected Systems/Organs
- ## Clinical Features
  background-color:: blue
	- ### Clinical Presentation
		- #### Symptoms
		- #### Signs
	- ### Stages or Classification
- ## Diagnosis
  background-color:: blue
	- ### Diagnostic Criteria
	- ### Investigation
		- ### Establishing Diagnosis
		- ### Ruling Out Differential Diagnosis
			- |DD|Ruling Out|
			  |--|--|
			  |d_d|r_o|
		- ### General Assessment
- ## Management and Treatment
  background-color:: blue
	- ### Medical Treatment
	  *hospitalisation*
		- ((6810a757-b94b-45b8-87e8-2814b359776b))
		- Antipyretics : Only Paracetamol
	- ### Lifestyle and Dietary Recommendations
		- warm fluids in diet
	- ### Follow-up
		- Monitor
			- Circulatory volume & haemodynamic status
			- Blood osmolality
			- Fluid & electrolytes balance
			- Intake-output chart
			- Platelet count and haematocrit, twice daily
		- Prevent or Treat complications
			- Evidence of bleeding
			- Evidence of pleural effusion or ascites
- ## Prognosis
  background-color:: blue
	- ### Expected Course
		- #### With Treatment
		- #### Without Treatment
			- ##### Possible Complications
			- ##### Long-Term Effects
	- ### Survival Rates
		- #### With Treatment
		- #### Without Treatment
	- ### Quality of Life Considerations
- ## Prevention
  background-color:: blue
	- ### Health Education
	- ### Community Approach
	- ### Screening Programs
	- ### Lifestyle Modifications
- ## Patient Education and Support
  background-color:: blue
	- ### Educational Resources
	- ### Support Groups
	- ### Counseling Options
- ## Recent Research and Developments
  background-color:: blue
	- ### Ongoing Clinical Trials
	- ### Recent Advances
- ## Key Literature
  background-color:: blue
- ## Guidelines and Protocols
  background-color:: blue